India's first intranasal vaccine for Covid gets DCGI approval

New Delhi, Sep 6 (IANS) India's first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a 'big boost to India's fight against Covid-19."Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation," Mandaviya tweeted.In the subsequent tweet he said, "This step will further strengthen our collective fight against the pandemic."India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji's leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19", he said.
--IANS avr/dpb

(Disclaimer: This post has been auto published from IANS news agency without any modification to the text and has not been reviewed by editor)